Laatste resultaten 22 jul 2026
Lonza Group AG
I · AI-analyse
In het kort
Lonza manufactures medicines and biologics under contract for pharmaceutical companies that need specialized production capabilities. They operate three main business lines: Integrated Biologics (growing living cells to make complex drugs), Advanced Synthesis (manufacturing small molecule drugs and antibody-drug conjugates), and Specialized Modalities (cell and gene therapies, mRNA production). Essentially, they are the factory for companies that develop medicines but lack the specialized manufacturing infrastructure to produce them at scale [Yahoo Finance].
Lonza Group AG is a Swiss contract development and manufacturing organization (CDMO) that produces complex medicines for pharmaceutical and biotech companies, operating across biologics, small molecules, and specialized therapies like cell and gene treatments [Yahoo Finance]. The company generated CHF 6,5B in revenue but faces moderate financial concerns with negative free cash flow of CHF -204M and a debt load of 2,8x EBITDA [Yahoo Finance]. With 20.000 employees globally, Lonza is positioned in the high-growth biologics manufacturing sector but trades at a premium 37,5x price-to-earnings ratio [Yahoo Finance].
Lonza shows mixed financial health with solid profitability margins but concerning cash flow and elevated debt levels.
Sentinellis-score
4,2/10
Aanzienlijke risico's
Marktkapitalisatie
CHF 34,1B
Omzet (12 maanden)
CHF 6,5B
Uitleg
Hoe wij deze cijfers lezen
Begrijpelijke gidsen · geen account nodig
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LezenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LezenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LezenII · Recent nieuws
Wat de koers bewoog
1 bericht · gesorteerd op relevantie
- Macro2026-05-19
Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
Yahoo Finance
Premium · gratis met elk account
Revenue contracted 0,7% year-over-year, indicating potential market headwinds or competitive pressures in Lonza's contract manufacturing segments [Yahoo Finance]
Risico's
5
Kansen
5
Waarschuwingssignalen
2
Leiding
10
Nog 11 bevindingen in het volledige rapport — gratis met elk account.
Ontgrendel de volledige analyse van Lonza Group AG
Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.
- 5 risico's, 5 kansen en 2 waarschuwingssignalen — elk met zijn bron
- Meer dan 100 financiële cijfers met grafieken en vergelijkingen
- Volledige nieuwssamenvattingen met bronlinks
- Directie en beloning
III · Vergelijkbare bedrijven
Misschien ook interessant
Zelfde sector · Gezondheidszorg — of vergelijkbare financiële gezondheid
Op je volglijst zetten?